Telomerase-based GX301 cancer vaccine in patients with metastatic castration-resistant prostate cancer: a randomized phase II trial.
Cancer Immunol Immunother
; 70(12): 3679-3692, 2021 Dec.
Article
in En
| MEDLINE
| ID: mdl-34351436
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Telomerase
/
Cancer Vaccines
/
Prostatic Neoplasms, Castration-Resistant
Type of study:
Clinical_trials
Limits:
Aged
/
Humans
/
Male
Language:
En
Journal:
Cancer Immunol Immunother
Journal subject:
ALERGIA E IMUNOLOGIA
/
NEOPLASIAS
/
TERAPEUTICA
Year:
2021
Type:
Article
Affiliation country:
Italy